Invention Grant
- Patent Title: Heteroarylamide inhibitors of TBK1
-
Application No.: US15123992Application Date: 2015-02-12
-
Publication No.: US09598424B2Publication Date: 2017-03-21
- Inventor: Walter Keung , Lily Kwok , Mark Sabat , Nicholas Scorah , Haixia Wang , Steven John Woodhead , Anthony R Gangloff
- Applicant: Takeda Pharmaceutical Company Limited
- Applicant Address: JP Osaka
- Assignee: Takeda Pharmaceutical Company Limited
- Current Assignee: Takeda Pharmaceutical Company Limited
- Current Assignee Address: JP Osaka
- Agent Matthew J. Russo; David M. Stemerick
- International Application: PCT/US2015/015651 WO 20150212
- International Announcement: WO2015/134171 WO 20150911
- Main IPC: C07D487/04
- IPC: C07D487/04 ; C07D471/04
Abstract:
The present invention provides compounds of formula 1: which are useful as inhibitors of TBK-1, pharmaceutical compositionst thereof, methods for treatment of conditions associated with TBK1, processes for making the compounds and intermediates thereof.
Public/Granted literature
- US20170015669A1 HETEROARYLAMIDE INHIBITORS OF TBK1 Public/Granted day:2017-01-19
Information query
